Medical Biotechnology articles for Netherlands

Time frame: 1 July 2025 - 30 June 2026

View topic

Count: 53

Article ‘Count’ for Medical Biotechnology.

Journal Count Share
3 1.18
“Visualize, Describe, Compare”─Nanoinformatics Approaches for Material-Omics 1.00
An Assembly-Line Mechanism for In Vitro Encapsulation of Fragmented Cargo in Virus-Like Particles 0.14
An Immunomodulating Regenerating Hydrogel That Rescues the Oxidative Microenvironment and Reverses Cell Senescence for Osteoporotic Bone Defects 0.03
1 1.00
Dynamic and static strain levels differentially affect the enzymatic degradation of collagen fibres 1.00
4 1.54
Multi-Responsive Dendrimer-Hyaluronic Acid Hydrogel With Lubricating and Immunoregulatory Functions for Synergistic Osteoarthritis Therapy 0.13
Poly(lactic-co-glycolic acid) Nanoparticles for IL-12 Self-Amplifying RNA Delivery in Glioblastoma Models 0.47
Mimicking Block Copolymer Self-Assembly with One-Pot Synthesized Polyphosphoester Gradient Copolymers 0.44
Revealing the Auxetic Behavior of Biomimetic Multimaterial and Region-Specific Nanofibrous Fascicle-Inspired Scaffolds via Synchrotron Multiscale Digital Volume Correlation: Innovative Building Blocks for the Enthesis Regeneration 0.50
3 1.12
Microbubble Shell Stiffness Engineering Enhances Ultrasound Imaging, Drug Delivery, and Sonoporation 0.03
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells 1.00
High‐Speed Raman Readout of Single Polypeptides via Plasmonic Nanopores 0.08
1 1.00
Assessment of Particle Size-Resolved Surface-Charge Density Distributions of Polymer Nanoparticles by Capillary Zone Electrophoresis 1.00
3 1.21
Thermostable Bioluminescent Intercalating Dyes for Real‐Time, Integrated Nucleic Acid Amplification and Detection 1.00
ATP-Powered Signaling Between Artificial and Living Cells 0.17
Functional Dendrimer Nanogels for DNA Delivery and Gene Therapy of Tumors 0.04
1 0.07
Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy 0.07
1 0.03
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trial 0.03
3 1.11
Plasma pTau 217:β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology 0.03
Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types 0.12
CSF proteomic profiles related to cognitive decline in MCI A+ depend on tau levels 0.96
1 0.64
Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer’s pathology and cognitive resilience 0.64
2 0.54
A platform to design and optimise fluorogenic scFvs for detection of interleukin 33 0.14
Degradable polyphosphoester-based aqueous two-phase systems and water-in-water emulsions 0.40
1 0.17
Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa 0.17
1 0.38
Baseline Risk and Longitudinal Changes in kidneyintelX.dkd and Its Association With Kidney Outcomes in the CANVAS and CREDENCE Trials. 0.38
1 0.09
Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials 0.09
1 0.43
KLF18 is a necessary component of the DUX4-initiated transcriptional network and a candidate locus for phenotypic diversity 0.43
1 0.11
The Development of Neural Inhibition across Species: Insights from the Hurst Exponent 0.11
1 1.00
Architecture-Encoded Degradation Kinetics and Pathways through the Shape and Size of Polymeric Vesicles 1.00
1 1.00
Architecting Well-Defined Glyco-Nanoparticles from pH- and Temperature-Responsive Glycosylated Triblock Terpolymers 1.00
1 0.58
Topology Determines DNA Origami Diffusion in Intestinal Mucus 0.58
9 2.17
Implementation determinants of rapid diagnostics tests for fever management in sub-Saharan Africa: a mixed-studies systematic review 0.03
Silk-Inspired Design and Manufacturing of Robust Plantymers 0.42
GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy 0.09
Single-molecule readout of reversible nanoswitches enables continuous monitoring of low biomarker concentrations 1.00
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum 0.10
Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate commitment 0.04
Spatial single-cell atlas reveals regional variations in healthy and diseased human lung 0.07
Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy 0.40
Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis 0.02
1 1.00
Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling 1.00
2 0.91
Ultrasound-responsive liposomes: A mechanistic framework to decode the effects of acoustic parameters 0.89
Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy 0.02
1 0.75
Kbtbd13 knockdown restores muscle function in a clinically relevant mouse model of nemaline myopathy type 6 0.75
2 1.10
Interferon-γ selectively promotes survival of alveolar progenitor cells in a human lung organoid model 1.00
Serum coating enables feeder-free culture of naive human pluripotent stem cells preserving developmental potential 0.10
1 0.23
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial 0.23
1 0.08
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study 0.08
5 0.41
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors 0.07
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT 0.10
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B 0.15
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk 0.03
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia 0.06

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.